Asymmetric synthesis and biosynthetic implications of (+)-fusarisetin A.
about
Fusarisetins: Structure-function studies on a novel class of cell migration inhibitorsStereochemical assignment of the protein-protein interaction inhibitor JBIR-22 by total synthesis.Fusarisetin A: Scalable Total Synthesis and Related Studies.Neurotrophic natural products: chemistry and biology.Natural product synthesis in the age of scalability.Transition metal-promoted biomimetic steps in total syntheses.Efficient total synthesis of bioactive natural products: a personal record.Applications of visible light photoredox catalysis to the synthesis of natural products and related compounds.Chemo-enzymatic synthesis of equisetin.Stereochemical Assignment of the Protein-Protein Interaction Inhibitor JBIR-22 by Total Synthesis.A photo-induced C-O bond formation methodology to construct tetrahydroxanthones.Catalytic asymmetric homologation of α-ketoesters with α-diazoesters: synthesis of succinate derivatives with chiral quaternary centers.Development of an expedient intramolecular Pauson-Khand reaction approach to stereoselectively construct the trans-decalin with a C1 quaternary chiral center.Biomimetic synthesis of equisetin and (+)-fusarisetin A.Synthetic studies on the bioactive tetramic acid JBIR-22 using a late stage Diels-Alder reaction.Complexity generation by chemical synthesis: a five-step synthesis of (-)-chaetominine from L-tryptophan and its biosynthetic implications.A lesson for site-selective C-H functionalization on 2-pyridones: radical, organometallic, directing group and steric controls.Recent Advances in the Total Synthesis of Tetramic Acid-Containing Natural Products
P2860
Q33705619-88EB624E-E570-48A8-9524-C3BF78DFD03FQ35636280-634F0D30-A91E-40DB-AE53-FBDF72BB878AQ36443912-B0B4EA5D-69B0-4C6B-A9DB-E1D6B247F505Q37623342-ADA9081F-5380-4B38-ACE4-7C5C8ECFDB60Q38171270-B5BD028E-D8A9-4814-8E81-CEE033F08AC4Q38183677-5FFD7DCE-2D26-4F37-A370-5FEB8C67327BQ38232014-0A3729AB-7308-4027-AA7C-CEE70CAFC53DQ38912094-6F616243-EF2A-4782-9FF9-899C627881F6Q40254853-3B0A0EF0-C926-4D2D-AF36-0FB6125DC18BQ42113444-D10DC199-AF2B-4899-8450-78CC4D0873A5Q43982306-ED1E7131-C734-43F9-B2BA-2E1163EC16F1Q44610025-7DD777F9-B884-4AAA-AA74-9E2E076E27E9Q46437502-9CD55475-6C18-47BE-8591-BD65D8E8937CQ50472859-8F2B78D9-DA9D-42EE-85C3-1316BA40D4A2Q53551690-41F21550-B352-4BE3-98BC-1C1CC0ED49F3Q53588509-3D68CD19-4602-498B-B806-B54C4D6A7F9DQ54935916-AA46891B-E0B3-424F-A05D-072599F1DC64Q59125761-5693E418-566C-41C8-8679-8EEE8E899B58
P2860
Asymmetric synthesis and biosynthetic implications of (+)-fusarisetin A.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Asymmetric synthesis and biosynthetic implications of (+)-fusarisetin A.
@en
Asymmetric synthesis and biosynthetic implications of
@nl
type
label
Asymmetric synthesis and biosynthetic implications of (+)-fusarisetin A.
@en
Asymmetric synthesis and biosynthetic implications of
@nl
prefLabel
Asymmetric synthesis and biosynthetic implications of (+)-fusarisetin A.
@en
Asymmetric synthesis and biosynthetic implications of
@nl
P2093
P2860
P356
P1476
Asymmetric synthesis and biosynthetic implications of (+)-fusarisetin A.
@en
P2093
P2860
P304
P356
10.1002/ANIE.201202455
P407
P577
2012-06-18T00:00:00Z